Joanne Manaster reviews two books about distinguishing science fact from science fiction in our everyday lives: Bad Science, by Ben Goldacre, and Lies, Damned Lies and Science, by Sherry Seethaler.
For more of Joanne's video reviews, see her web page, Joanne Loves Science, or her science reviews YouTube channel.
- Log in to post comments
More like this
Here's something new, ScienceBlogs Book Clubbers—hopefully the first of many. When we stumbled across Joanne Manaster's science book review channel on YouTube, we were riveted, and we thought you might be, too. We will be posting Joanne's videos here on an informal, ongoing basis, and we've listed…
Joanne Manaster of Joanne Loves Science has just announced a science book reading contest for young readers (and movie-makers): Kids Read Science and Teens Read Science. Watch the introductory video:
Check out the contest instructions for details:
The contest is simple--just do what I do quite…
By Stacy Jannis
The Kavli Science in Fiction Video Contest challenges Gr 6-12 students to examine the science in fiction, including science fiction movies, TV shows, and games. Our contest advisors include science educators , scientists, and Hollywood scifi visual effects experts. Follow #…
For more video book reviews by Joanne Manaster, see her page on YouTube.
Good for your 1-year-old, not so much. Technically, that's still a matter of opinion, sort of: studies on television watching in infancy have been mostly limited to retrospective analyses. With these kinds of studies, we can make plenty of associations between watching TV and delayed development, but we can't prove a causative relationship between the two.
And, certainly, so long as I wasn't identifiable. If I wasn't identifiable to myself, then I'd certainly not have any objections at all.
Thanks to all for the kind words, and for reading.
Shinga, I'll put in a second plug for the post you've linked to. It probably belongs in GR itself in the sense that it highlights the limitations of data gathering and analysis as we know it and makes some not-unreasonable speculation about the direction of clinical trials from here on out.